Key Points

  • The cyclic resveratrol trimer caraphenol A safely enhances lentiviral vector gene delivery to hematopoietic stem and progenitor cells.

  • Caraphenol A decreases interferon-induced transmembrane protein-mediated restriction in an endosomal trafficking-dependent manner.

Abstract

Therapeutic gene delivery to hematopoietic stem cells (HSCs) holds great potential as a life-saving treatment of monogenic, oncologic, and infectious diseases. However, clinical gene therapy is severely limited by intrinsic HSC resistance to modification with lentiviral vectors (LVs), thus requiring high doses or repeat LV administration to achieve therapeutic gene correction. Here we show that temporary coapplication of the cyclic resveratrol trimer caraphenol A enhances LV gene delivery efficiency to human and nonhuman primate hematopoietic stem and progenitor cells with integrating and nonintegrating LVs. Although significant ex vivo, this effect was most dramatically observed in human lineages derived from HSCs transplanted into immunodeficient mice. We further show that caraphenol A relieves restriction of LV transduction by altering the levels of interferon-induced transmembrane (IFITM) proteins IFITM2 and IFITM3 and their association with late endosomes, thus augmenting LV core endosomal escape. Caraphenol A-mediated IFITM downregulation did not alter the LV integration pattern or bias lineage differentiation. Taken together, these findings compellingly demonstrate that the pharmacologic modification of intrinsic immune restriction factors is a promising and nontoxic approach for improving LV-mediated gene therapy.

REFERENCES

REFERENCES
1.
Aiuti
A
,
Cattaneo
F
,
Galimberti
S
, et al
.
Gene therapy for immunodeficiency due to adenosine deaminase deficiency
.
N Engl J Med
.
2009
;
360
(
5
):
447
-
458
.
2.
Aiuti
A
,
Biasco
L
,
Scaramuzza
S
, et al
.
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome
.
Science
.
2013
;
341
(
6148
):
1233151
.
3.
Biffi
A
,
Montini
E
,
Lorioli
L
, et al
.
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy
.
Science
.
2013
;
341
(
6148
):
1233158
.
4.
Adair
JE
,
Becker
PS
,
Chandrasekaran
D
, et al
.
Gene therapy for Fanconi anemia in Seattle: Clinical experience and next steps
.
Blood
.
2016
;
128
(
22
):
3510
.
5.
Thompson
AA
,
Walters
MC
,
Kwiatkowski
J
, et al
.
Gene therapy in patients with transfusion-dependent β-thalassemia
.
N Engl J Med
.
2018
;
378
(
16
):
1479
-
1493
.
6.
Ribeil
J-A
,
Hacein-Bey-bina
S
,
Payen
E
, et al
.
Gene therapy in a patient with sickle cell disease
.
N Engl J Med
.
2017
;
376
(
9
):
848
-
855
.
7.
Biffi
A
.
Hematopoietic stem cell gene therapy for storage disease: current and new indications
.
Mol Ther
.
2017
;
25
(
5
):
1155
-
1162
.
8.
Kumar
SRP
,
Markusic
DM
,
Biswas
M
,
High
KA
,
Herzog
RW
.
Clinical development of gene therapy: results and lessons from recent successes
.
Mol Ther Methods Clin Dev
.
2016
;
3
:
16034
.
9.
Santoni de Sio
FR
,
Cascio
P
,
Zingale
A
,
Gasparini
M
,
Naldini
L
.
Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction
.
Blood
.
2006
;
107
(
11
):
4257
-
4265
.
10.
Ailles
L
,
Schmidt
M
,
Santoni de Sio
FR
, et al
.
Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells
.
Mol Ther
.
2002
;
6
(
5
):
615
-
626
.
11.
Mazurier
F
,
Gan
OI
,
McKenzie
JL
,
Doedens
M
,
Dick
JE
.
Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment
.
Blood
.
2004
;
103
(
2
):
545
-
552
.
12.
Girard-Gagnepain
A
,
Amirache
F
,
Costa
C
, et al
.
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs
.
Blood
.
2014
;
124
(
8
):
1221
-
1231
.
13.
Lévy
C
,
Amirache
F
,
Girard-Gagnepain
A
, et al
.
Measles virus envelope pseudotyped lentiviral vectors transduce quiescent human HSCs at an efficiency without precedent
.
Blood Adv
.
2017
;
1
(
23
):
2088
-
2104
.
14.
Ozog
S
,
Chen
CX
,
Simpson
E
, et al
.
CD46 null packaging cell line improves measles lentiviral vector production and gene delivery to hematopoietic stem and progenitor cells
.
Mol Ther Methods Clin Dev
.
2019
;
13
:
27
-
39
.
15.
Wang
CX
,
Sather
BD
,
Wang
X
, et al
.
Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells
.
Blood
.
2014
;
124
(
6
):
913
-
923
.
16.
Heffner
GC
,
Bonner
M
,
Christiansen
L
, et al
.
Prostaglandin E2 increases lentiviral vector transduction efficiency of adult human hematopoietic stem and progenitor cells
.
Mol Ther
.
2018
;
26
(
1
):
320
-
328
.
17.
Petrillo
C
,
Thorne
LG
,
Unali
G
, et al
.
Cyclosporine H Overcomes innate immune restrictions to improve lentiviral transduction and gene editing in human hematopoietic stem cells
.
Cell Stem Cell
.
2018
;
23
(
6
):
820
-
832
.
18.
Kajaste-Rudnitski
A
,
Naldini
L
.
Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cells
.
Hum Gene Ther
.
2015
;
26
(
4
):
201
-
209
.
19.
Amirache
F
,
Lévy
C
,
Costa
C
, et al
.
Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor
.
Blood
.
2014
;
123
(
9
):
1422
-
1424
.
20.
Shen
H
,
Cheng
T
,
Preffer
FI
, et al
.
Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression
.
J Virol
.
1999
;
73
(
1
):
728
-
737
.
21.
Zhang
J
,
Scadden
DT
,
Crumpacker
CS
.
Primitive hematopoietic cells resist HIV-1 infection via p21
.
J Clin Invest
.
2007
;
117
(
2
):
473
-
481
.
22.
Villa
NY
,
Bais
S
,
Chan
WM
, et al
.
Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells
.
Cytotherapy
.
2016
;
18
(
3
):
465
-
480
.
23.
Griffin
DO
,
Goff
SP
.
HIV-1 is restricted prior to integration of viral DNA in primary cord-derived human CD34+ cells
.
J Virol
.
2015
;
89
(
15
):
8096
-
8100
.
24.
Kolb-Mäurer
A
,
Wilhelm
M
,
Weissinger
F
,
Bröcker
E-B
,
Goebel
W
.
Interaction of human hematopoietic stem cells with bacterial pathogens
.
Blood
.
2002
;
100
(
10
):
3703
-
3709
.
25.
Pascutti
MF
,
Erkelens
MN
,
Nolte
MA
.
Impact of viral infections on hematopoiesis: from beneficial to detrimental effects on bone marrow output
.
Front Immunol
.
2016
;
7
:
364
.
26.
Wu
X
,
Dao Thi
VL
,
Huang
Y
, et al
.
Intrinsic immunity shapes viral resistance of stem cells
.
Cell
.
2018
;
172
(
3
):
423
-
438
.
27.
Alber
D
,
Staeheli
P
.
Partial inhibition of vesicular stomatitis virus by the interferon-induced human 9-27 protein
.
J Interferon Cytokine Res
.
1996
;
16
(
5
):
375
-
380
.
28.
Hornick
AL
,
Li
N
,
Oakland
M
,
McCray
PB
Jr
,
Sinn
PL
.
Human, pig, and mouse interferon-induced transmembrane proteins partially restrict pseudotyped lentiviral vectors
.
Hum Gene Ther
.
2016
;
27
(
5
):
354
-
362
.
29.
Roesch
F
,
OhAinle
M
,
Emerman
M
.
A CRISPR screen for factors regulating SAMHD1 degradation identifies IFITMs as potent inhibitors of lentiviral particle delivery
.
Retrovirology
.
2018
;
15
(
1
):
26
.
30.
Shi
G
,
Schwartz
O
,
Compton
AA
.
More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins
.
Retrovirology
.
2017
;
14
(
1
):
53
.
31.
Siegrist
F
,
Ebeling
M
,
Certa
U
.
The small interferon-induced transmembrane genes and proteins
.
J Interferon Cytokine Res
.
2011
;
31
(
1
):
183
-
197
.
32.
Shi
G
,
Ozog
S
,
Torbett
BE
,
Compton
AA
.
mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3
.
Proc Natl Acad Sci USA
.
2018
;
115
(
43
):
E10069
-
E10078
.
33.
Li
J
,
Kim
SG
,
Blenis
J
.
Rapamycin: one drug, many effects
.
Cell Metab
.
2014
;
19
(
3
):
373
-
379
.
34.
Lewis
G
,
Christiansen
L
,
McKenzie
J
, et al
.
Staurosporine increases lentiviral vector transduction efficiency of human hematopoietic stem and progenitor cells
.
Mol Ther Methods Clin Dev
.
2018
;
9
:
313
-
322
.
35.
Yu
D
,
Wang
W
,
Yoder
A
,
Spear
M
,
Wu
Y
.
The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells
.
PLoS Pathog
.
2009
;
5
(
10
):
e1000633
.
36.
Wright
NE
,
Snyder
SA
.
9-Membered carbocycle formation: development of distinct Friedel-Crafts cyclizations and application to a scalable total synthesis of (±)-caraphenol A
.
Angew Chem Int Ed Engl
.
2014
;
53
(
13
):
3409
-
3413
.
37.
Swan
CH
,
Bühler
B
,
Steinberger
P
,
Tschan
MP
,
Barbas
CF
III
,
Torbett
BE
.
T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery [published correction appears in Gene Ther. 2007;14(7):626]
.
Gene Ther
.
2006
;
13
(
20
):
1480
-
1492
.
38.
Kutner
RH
,
Zhang
XY
,
Reiser
J
.
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
.
Nat Protoc
.
2009
;
4
(
4
):
495
-
505
.
39.
Bobrowska-Hägerstrand
M
,
Lillås
M
,
Mrówczyñska
L
, et al
.
Resveratrol oligomers are potent MRP1 transport inhibitors
.
Anticancer Res
.
2006
;
26
(
3A 3a
):
2081
-
2084
.
40.
Chung
EY
,
Kim
BH
,
Lee
MK
, et al
.
Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase
.
Planta Med
.
2003
;
69
(
8
):
710
-
714
.
41.
Chung
EY
,
Roh
E
,
Kwak
JA
, et al
.
alpha-Viniferin suppresses the signal transducer and activation of transcription-1 (STAT-1)-inducible inflammatory genes in interferon-gamma-stimulated macrophages
.
J Pharmacol Sci
.
2010
;
112
(
4
):
405
-
414
.
42.
González-Sarrías
A
,
Gromek
S
,
Niesen
D
,
Seeram
NP
,
Henry
GE
.
Resveratrol oligomers isolated from Carex species inhibit growth of human colon tumorigenic cells mediated by cell cycle arrest
.
J Agric Food Chem
.
2011
;
59
(
16
):
8632
-
8638
.
43.
Kim
DH
,
Kim
SH
,
Kim
HJ
,
Jin
C
,
Chung
KC
,
Rhim
H
.
Stilbene derivatives as human 5-HT(6) receptor antagonists from the root of Caragana sinica
.
Biol Pharm Bull
.
2010
;
33
(
12
):
2024
-
2028
.
44.
Yan
T
,
Wang
T
,
Wei
W
, et al
.
Polyphenolic acetylcholinesterase inhibitors from Hopea chinensis
.
Planta Med
.
2012
;
78
(
10
):
1015
-
1019
.
45.
Quideau
S
,
Deffieux
D
,
Douat-Casassus
C
,
Pouységu
L
.
Plant polyphenols: chemical properties, biological activities, and synthesis
.
Angew Chem Int Ed Engl
.
2011
;
50
(
3
):
586
-
621
.
46.
Keylor
MH
,
Matsuura
BS
,
Stephenson
CRJ
.
Chemistry and biology of resveratrol-derived natural products
.
Chem Rev
.
2015
;
115
(
17
):
8976
-
9027
.
47.
Snyder
SA
,
Gollner
A
,
Chiriac
MI
.
Regioselective reactions for programmable resveratrol oligomer synthesis
.
Nature
.
2011
;
474
(
7352
):
461
-
466
.
48.
Keylor
MH
,
Matsuura
BS
,
Griesser
M
, et al
.
Synthesis of resveratrol tetramers via a stereoconvergent radical equilibrium
.
Science
.
2016
;
354
(
6317
):
1260
-
1265
.
49.
Rimmelé
P
,
Lofek-Czubek
S
,
Ghaffari
S
.
Resveratrol increases the bone marrow hematopoietic stem and progenitor cell capacity
.
Am J Hematol
.
2014
;
89
(
12
):
E235
-
E238
.
50.
Heinz
N
,
Ehrnström
B
,
Schambach
A
,
Schwarzer
A
,
Modlich
U
,
Schiedlmeier
B
.
Comparison of different cytokine conditions reveals resveratrol as a new molecule for ex vivo cultivation of cord blood-derived hematopoietic stem cells
.
Stem Cells Transl Med
.
2015
;
4
(
9
):
1064
-
1072
.
51.
Pollok
KE
,
van Der Loo
JC
,
Cooper
RJ
, et al
.
Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood
.
Hum Gene Ther
.
2001
;
12
(
17
):
2095
-
2108
.
52.
DiGiusto
DL
,
Krishnan
A
,
Li
L
, et al
.
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma
.
Sci Transl Med
.
2010
;
2
(
36
):
36ra43
.
53.
Cavazzana-Calvo
M
,
Payen
E
,
Negre
O
, et al
.
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
.
Nature
.
2010
;
467
(
7313
):
318
-
322
.
54.
Cartier
N
,
Hacein-Bey-Abina
S
,
Bartholomae
CC
, et al
.
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy
.
Science
.
2009
;
326
(
5954
):
818
-
823
.
55.
Petrillo
C
,
Cesana
D
,
Piras
F
, et al
.
Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells
.
Mol Ther
.
2015
;
23
(
2
):
352
-
362
.
56.
Li
L
,
Torres-Coronado
M
,
Gu
A
, et al
.
Enhanced genetic modification of adult growth factor mobilized peripheral blood hematopoietic stem and progenitor cells with rapamycin
.
Stem Cells Transl Med
.
2014
;
3
(
10
):
1199
-
1208
.
57.
Le Blanc
K
,
Barrett
AJ
,
Schaffer
M
, et al
.
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies
.
Biol Blood Marrow Transplant
.
2009
;
15
(
9
):
1108
-
1115
.
58.
De Ravin
SS
,
Wu
X
,
Moir
S
, et al
.
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency
.
Sci Transl Med
.
2016
;
8
(
335
):
335ra57
.
59.
Berman
AY
,
Motechin
RA
,
Wiesenfeld
MY
,
Holz
MK
.
The therapeutic potential of resveratrol: a review of clinical trials
.
NPJ Precis Oncol
.
2017
;
1
:
35
.
60.
Beard
BC
,
Adair
JE
,
Trobridge
GD
,
Kiem
HP
.
High-throughput genomic mapping of vector integration sites in gene therapy studies
.
Methods Mol Biol
.
2014
;
1185
:
321
-
344
.
61.
Takeuchi
K
,
Miyajima
N
,
Nagata
N
,
Takeda
M
,
Tashiro
M
.
Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism
.
Virus Res
.
2003
;
94
(
1
):
11
-
16
.
62.
Gonçalves-Carneiro
D
,
McKeating
JA
,
Bailey
D
.
The Measles virus receptor SLAMF1 can mediate particle endocytosis
.
J Virol
.
2017
;
91
(
7
):
e02255
-
e02216
.
63.
Le Blanc
I
,
Luyet
P-P
,
Pons
V
, et al
.
Endosome-to-cytosol transport of viral nucleocapsids
.
Nat Cell Biol
.
2005
;
7
(
7
):
653
-
664
.
64.
Cavrois
M
,
De Noronha
C
,
Greene
WC
.
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
.
Nat Biotechnol
.
2002
;
20
(
11
):
1151
-
1154
.
65.
Miyauchi
K
,
Kim
Y
,
Latinovic
O
,
Morozov
V
,
Melikyan
GB
.
HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes
.
Cell
.
2009
;
137
(
3
):
433
-
444
.
66.
Mbisa
JL
,
Delviks-Frankenberry
KA
,
Thomas
JA
,
Gorelick
RJ
,
Pathak
VK
.
Real-time PCR analysis of HIV-1 replication post-entry events
.
Methods Mol Biol
.
2009
;
485
:
55
-
72
.
67.
Huang
IC
,
Bailey
CC
,
Weyer
JL
, et al
.
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus
.
PLoS Pathog
.
2011
;
7
(
1
):
e1001258
.
68.
Feeley
EM
,
Sims
JS
,
John
SP
, et al
.
IFITM3 inhibits influenza A virus infection by preventing cytosolic entry
.
PLoS Pathog
.
2011
;
7
(
10
):
e1002337
.
69.
Weidner
JM
,
Jiang
D
,
Pan
X-B
,
Chang
J
,
Block
TM
,
Guo
J-T
.
Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms
.
J Virol
.
2010
;
84
(
24
):
12646
-
12657
.
70.
Gerlach
T
,
Hensen
L
,
Matrosovich
T
, et al
.
pH optimum of hemagglutinin-mediated membrane fusion determines sensitivity of influenza A viruses to the interferon-induced antiviral state and IFITMs
.
J Virol
.
2017
;
91
(
11
):
e00246
-
17
.
71.
Fu
Y
,
Zhou
Z
,
Wang
H
, et al
.
IFITM1 suppresses expression of human endogenous retroviruses in human embryonic stem cells
.
FEBS Open Bio
.
2017
;
7
(
8
):
1102
-
1110
.
72.
Grow
EJ
,
Flynn
RA
,
Chavez
SL
, et al
.
Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells
.
Nature
.
2015
;
522
(
7555
):
221
-
225
.
73.
Jia
R
,
Pan
Q
,
Ding
S
, et al
.
The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization
.
J Virol
.
2012
;
86
(
24
):
13697
-
13707
.
74.
Sutton
RE
,
Reitsma
MJ
,
Uchida
N
,
Brown
PO
.
Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent
.
J Virol
.
1999
;
73
(
5
):
3649
-
3660
.
75.
Park
D
,
Jeong
H
,
Lee
MN
, et al
.
Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition
.
Sci Rep
.
2016
;
6
(
1
):
21772
.
76.
Ghosh
HS
,
McBurney
M
,
Robbins
PD
.
SIRT1 negatively regulates the mammalian target of rapamycin
.
PLoS One
.
2010
;
5
(
2
):
e9199
.
77.
Puissant
A
,
Robert
G
,
Fenouille
N
, et al
.
Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation
.
Cancer Res
.
2010
;
70
(
3
):
1042
-
1052
.
78.
Spence
JS
,
He
R
,
Hoffmann
H-H
, et al
.
IFITM3 directly engages and shuttles incoming virus particles to lysosomes
.
Nat Chem Biol
.
2019
;
15
(
3
):
259
-
268
.
79.
Wee
YS
,
Roundy
KM
,
Weis
JJ
,
Weis
JH
.
Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function
.
Innate Immun
.
2012
;
18
(
6
):
834
-
845
.
80.
Perreira
JM
,
Chin
CR
,
Feeley
EM
,
Brass
AL
.
IFITMs restrict the replication of multiple pathogenic viruses
.
J Mol Biol
.
2013
;
425
(
24
):
4937
-
4955
.
81.
Everitt
AR
,
Clare
S
,
Pertel
T
, et al;
MOSAIC Investigators
.
IFITM3 restricts the morbidity and mortality associated with influenza
.
Nature
.
2012
;
484
(
7395
):
519
-
523
.
82.
Allen
EK
,
Randolph
AG
,
Bhangale
T
, et al
.
SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans
.
Nat Med
.
2017
;
23
(
8
):
975
-
983
.
83.
Zhang
D
,
Wang
H
,
He
H
,
Niu
H
,
Li
Y
.
Interferon induced transmembrane protein 3 regulates the growth and invasion of human lung adenocarcinoma
.
Thorac Cancer
.
2017
;
8
(
4
):
337
-
343
.
84.
Yang
M
,
Gao
H
,
Chen
P
,
Jia
J
,
Wu
S
.
Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle
.
Oncol Rep
.
2013
;
30
(
1
):
171
-
178
.
You do not currently have access to this content.